Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexiline for Myocardial Protection in LVH
NCT00989508Phase 3Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Oct 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perhexiline in myocardial reperfusion injury, sponsored by University Hospitals Birmingham. Status: unknown.
02
Drugs
perhexiline
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT00989508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989508.